HIGHLIGHTS
- who: NABIEL MIKHAIL from the Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt have published the research work: (MJVH) Anti-cancer activity of hesperidin against hepatocellular carcinoma-induced in rats through upregulation of RIPK1 expression, in the Journal: (JOURNAL)
- what: This study showed a significant decline in hepatic RIPK1 protein level in the TAA group in comparison with the control group, which matches previous results 29-30.
- how: Analysis of variance (ANOVA) then Tukey`s post-hoc test was employed to compare groups. This result is compatible with previous research 15 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.